Cargando…
Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report
Although anaphylaxis during anaesthesia is a rare event, neuromuscular blocking drugs are responsible for 62% of anaesthesia-related anaphylaxis. However, sugammadex, a modified gamma-cyclodextrin, can encapsulate rocuronium molecules and cause the rapid reversal of the neuromuscular blockade. A 68-...
Autores principales: | Hung, Sheng-Kai, Yeh, Chia-Chi, Ting, Pei-Chi, Chen, Cay-Huyen, Kao, Ming-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315254/ https://www.ncbi.nlm.nih.gov/pubmed/35869623 http://dx.doi.org/10.1177/03000605221113913 |
Ejemplares similares
-
Sugammadex and rocuronium-induced anaphylaxis
por: Takazawa, Tomonori, et al.
Publicado: (2015) -
Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
por: Choi, Shu Chung, et al.
Publicado: (2020) -
Treatment of rocuronium-induced anaphylaxis using sugammadex - A case report -
por: Kim, Sun-Min, et al.
Publicado: (2021) -
Possible mitigation of rocuronium-induced anaphylaxis after administration of sugammadex
por: Motamed, Cyrus, et al.
Publicado: (2012) -
Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020)